体外膜氧合桥接肺移植与移植后死亡率改善相关
该回顾性队列研究利用UNOS数据库分析2005至2017年20,976例肺移植患者,其中611例(2.9%)接受桥接肺移植的ECMO。结果显示BTT ECMO总体与移植后死亡风险增加相关(HR 1.37,95%CI 1.14-1.64),但在年移植量超过35例的高容量中心,这种风险增加不再显著。
要点
- BTT ECMO总体与肺移植后死亡风险增加相关(HR 1.37)
- 高容量中心(年移植量>35例)可消除BTT ECMO的额外死亡风险
- 低容量中心使用BTT ECMO需谨慎评估风险收益
核心结论
- 在高容量肺移植中心(年移植量超过35例),BTT ECMO可作为桥接手段而不显著增加患者死亡率。
研究设计与样本
- 回顾性队列研究,利用UNOS数据库分析2005至2017年接受肺移植的20,976例患者,其中611例(2.9%)接受BTT ECMO。
- 根据前5年平均年肺移植量将中心分为3组:少于25例、25至49例、超过50例。
- 采用倾向性评分加权比例风险模型比较BTT ECMO与非ECMO患者的生存。
主要发现
- 总体BTT ECMO与移植后死亡风险增加相关(HR 1.37;95%CI 1.14至1.64)。
- 按中心容量分层的Kaplan-Meier曲线提示高容量中心BTT ECMO相关死亡率可能被减轻。
- 倾向性评分加权模型显示,当年移植量超过35例时,BTT ECMO的死亡风险增加不再观察到。
关键数值与推荐
- BTT ECMO总体移植后死亡HR 1.37(95%CI 1.14-1.64)。
- 中心年移植量超过35例时,BTT ECMO的死亡风险增加不再显著。
临床怎么用
- 在高容量肺移植中心(年移植量>35例),可考虑将BTT ECMO作为桥接肺移植的手段。
- 低容量中心开展BTT ECMO桥接肺移植需谨慎评估风险。
局限性
- 回顾性研究设计存在选择偏倚可能。
- 未报告其他混杂因素的具体调整情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Our objective was to evaluate the association of bridge to transplant (BTT) extracorporeal membrane oxygenation (ECMO) on survival after lung transplantation (LTx) and determine the degree to which transplant center volume affects this relationship. METHODS: Using the United Network for Organ Sharing database, we performed a retrospective cohort study evaluating the survival of patients undergoing LTx between 2005 and 2017. On the basis of previous literature, LTx centers were classified into 3 groups using their average annual LTx volume over the preceding 5 years: less than 25, 25 to 49, and more than 50. Survival of BTT ECMO and non-ECMO patients was analyzed using a log-rank test. Propensity scores for BTT ECMO were calculated, and a weighted proportional hazards model was used to compare BTT ECMO and non-ECMO patients by center volume. RESULTS: There were 20,976 patients who met inclusion criteria, with 611 (2.9%) undergoing BTT ECMO. Overall, BTT ECMO was associated with increased posttransplantation hazard of mortality (hazard ratio, 1.37; 95% confidence interval, 1.14 to 1.64). Kaplan-Meier plots by center volume suggest that BTT ECMO-associated mortality may be mitigated at high-volume LTx centers. In the propensity score-weighted proportional hazards model, we determined that when centers perform more than 35 LTxs per year, the increased hazard of BTT ECMO on mortality is no longer observed. CONCLUSIONS: BTT ECMO can be performed as a bridge to LTx without significantly increasing patient mortality in high-volume centers. Patients undergoing BTT ECMO at LTx centers that perform more than 35 LTxs annually have equivalent mortality to those who do not require ECMO before transplantation.
引用
- Halpern AL, Kohtz PD, Helmkamp L, et al. Improved Mortality Associated With the Use of Extracorporeal Membrane Oxygenation. Ann Thorac Surg. 2019. PMID: 31009629. doi:10.1016/j.athoracsur.2019.03.057
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。